Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APLNR | P35414 | 2/20 | 0.62 |
| ▸ | CTSL | P07711 | 3/20 | 0.60 |
| ▸ | CTSS | P25774 | 3/20 | 0.60 |
| ▸ | CTSK | P43235 | 3/20 | 0.60 |
| ▸ | CTSH | P09668 | 1/20 | 0.60 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.58 |
| ▸ | CALCR | P30988 | 7/20 | 0.57 |
| ▸ | MC4R | P32245 | 1/20 | 0.56 |
| ▸ | RAMP3 | O60896 | 4/20 | 0.56 |
| ▸ | GLP1R | P43220 | 3/20 | 0.55 |
| ▸ | GCGR | P47871 | 2/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29695502 | 0.90 | APLNR (0.64) | APLNRCTSLCTSSCTSKCTSH | |
| SCHEMBL31295720 | 0.89 | CALCR (0.65) | APLNRCTSLCTSSCTSKCTSH | |
| SCHEMBL29606611 | 0.88 | CALCR (0.72) | APLNRKEAP1CALCRRAMP3GLP1R | |
| SCHEMBL30455824 | 0.87 | MAPK8 (0.57) | APLNRKEAP1CALCRMC4RRAMP3 | |
| SCHEMBL29949373 | 0.87 | CALCR (0.70) | APLNRKEAP1CALCRGLP1RGCGR | |
| SCHEMBL30185050 | 0.86 | APLNR (0.62) | APLNRCTSLCTSSCTSKCTSH | |
| SCHEMBL30437391 | 0.86 | APLNR (0.67) | APLNRKEAP1CALCRMC4RGLP1R | |
| SCHEMBL30524357 | 0.86 | APLNR (0.67) | APLNRCTSLCTSSCTSKCTSH | |
| SCHEMBL31688333 | 0.86 | APLNR (0.65) | APLNRCALCRMC4RRAMP3GLP1R | |
| SCHEMBL29362632 | 0.85 | APLNR (0.61) | APLNRCALCRMC4RRAMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230193291-A1 | METHOD FOR PRODUCING BLOCKPOYMERS BY MEANS OF LINKING BLOCKS BY A TRANSPEPTIDASE, AND BLOCK POLYMERS OBTAINED BY TRANSPEPTIDASE LINKING | FRAUNHOFER GES FORSCHUNG (DE) | 2023-06-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230193291-A1 | METHOD FOR PRODUCING BLOCKPOYMERS BY MEANS OF LINKING BLOCKS BY A TRANSPEPTIDASE, AND BLOCK POLYMERS OBTAINED BY TRANSPEPTIDASE LINKING | RNPEP, DNPEP, ENPEP | APLNR 320/4885CTSL 252/4885CTSS 413/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.